Saudi’s Madeed raises $925K to develop preventive health platform

A Saudi startup is betting that the future of healthcare in the region will be proactive, not reactive. Madeed, based in Riyadh, just secured additional pre-seed funding that brings its total to $925,000.

The company uses advanced laboratory testing and AI to identify early risk signals for hundreds of diseases before symptoms appear. It's part of a growing shift toward personalized, data-driven health management in a region where healthcare systems traditionally focus on treatment rather than prevention.

The funds will be used for

Madeed plans to use the new capital for several key areas:

• Developing the platform's products and technology
• Expanding clinical and laboratory partnerships across the region
• Initial focus on the Saudi market for broader service launch
• Accelerating platform growth beyond the pilot phase

The funding round was backed by SEEDRA Ventures, Unity Investment Partners, and Seen Growth. This builds on earlier support from Vision Ventures and Saudi investors.

Why does it matter?

Preventive healthcare remains underdeveloped across much of the MENA region. Most healthcare systems are structured around treating illness rather than preventing it in the first place.

Madeed's approach taps into several important trends:

• Growing demand for personalized healthcare solutions
• Increased use of AI in medical diagnostics
• Shift toward lifestyle optimization and wellness
• Saudi Arabia's national priority on healthcare transformation

"We dedicated the past period to conducting the necessary operational tests on the platform to ensure its efficiency, smooth operation, and the integration of the services offered," said Dr. Adam Bataineh, founder and CEO of Madeed.

The context

Madeed's raise reflects growing investor interest in healthtech across the region. Startups working in diagnostics, wellness, and AI-driven healthcare are attracting early-stage capital, particularly in Saudi Arabia.

The company has already onboarded 150 users during testing. Its partnership-led approach with labs and clinical providers shows how healthtech startups may integrate with existing healthcare infrastructure rather than replace it entirely.

This collaborative model could signal a new ecosystem where traditional healthcare providers and tech platforms evolve together. For the broader market, Madeed's rollout will be an early test of how receptive Saudi consumers are to preventive, subscription-based healthcare models.

The company's next phase will show whether early traction can scale and how preventive healthcare solutions can be successfully introduced in local markets across the region.